MTOR and ovarian carcinoma: CCL2 released by omental adipocytes facilitates the migration and omental metastasis of ovarian cancer through the activation of PI3K/AKT/mTOR followed by an increase in HIF-1α and vascular endothelial growth factor A (VEGF-A) [146].